Novartis AG
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people's lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach nearly 300 million people worldwide.
Profit margin of 23.9% — that's well above average.
Current Price
$146.57
-0.87%GoodMoat Value
$194.53
32.7% undervaluedNovartis AG (NVS) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Novartis AG's financial performance and position as a Healthcare company.
Trailing twelve-month (TTM) revenue is $56.58B. Gross profit (TTM) is $42.65B. EBITDA is $28.03B. Earnings per share (EPS) is $7.15. The P/E ratio is 20.66. Market capitalization is $279.68B.
Free cash flow (FCF) is $17.61B. FCF growth rate is 5.05%. EPS growth CAGR is 2.97%. Weighted average cost of capital (WACC) is 10.00%.
Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.
Use Novartis AG's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.
